Bayer starts enrolment for Phase III uterine fibroids trial in US
Bayer has started patient enrolment for a Phase III ASTEROID clinical trial of vilaprisan to treat patients with uterine fibroids in the US.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Clinical Trials | Pharmaceuticals